Background Hepatocellular carcinoma (HCC) is subject to different management
approaches and guidelines according to Eastern and Western therapeutic algorithms. Use …

Background This retrospective analysis was undertaken to evaluate the efficiency of SIRT
with Y-90 microspheres and determined prognostic factors affecting patients with …

About 80% of hepatocellular carcinoma (HCC) patients are in advanced stages and
ineligible for curative surgery. Palliative treatments just maintained limited survival, thus an …

Purpose We sought to report outcomes and toxicity in patients with hepatocellular carcinoma
(HCC) who received resin yttrium-90 selective internal radiation therapy (90Y-SIRT) and to …

Hepatocellular carcinoma (HCC), the predominant form of primary liver cancer, is the
second leading cause of cancer‐related deaths across the globe. Only a small percentage …

PURPOSE: This article reviews the role of selective internal irradiation (SIR) with yttrium-90
(90Y) microspheres for hepatocellular carcinoma (HCC). METHODS AND MATERIALS …

Background Selective internal radiation therapy (SIRT) with yttrium-90 resin (Y-90 resin)
microspheres has been used as a locoregional therapy for patients with unresectable …

Background Sorafenib is the recommended treatment for patients with advanced
hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that …

Hepatocellular carcinoma is the most common primary liver cancer and it represents the
majority of cancer-related deaths in the world. More than 70% of patients present at an …

Background Untreated advanced hepatocellular carcinoma (HCC) is linked to poor
prognosis. While sorafenib is the current recommended treatment for advanced HCC …